AUA 2018: Selection of Appropriate Genitourinary Cancers for Immunotherapy – UroToday
|
AUA 2018: Selection of Appropriate Genitourinary Cancers for Immunotherapy
UroToday He highlighted FDA approved indications for immunotherapy in genitourinary oncology, including for urothelial carcinoma and clear cell renal cell carcinoma. Additionally, patients with high grade advanced castration-resistant prostate cancer with high … |
